The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) impact survival in metastatic colorectal cancer (MCRC)?
Anuradha Jayaram
No relevant relationships to disclose
MinYuen Teo
No relevant relationships to disclose
Niamh Keegan
No relevant relationships to disclose
Emily Harrold
No relevant relationships to disclose
Niamh Coleman
No relevant relationships to disclose
M. John Kennedy
No relevant relationships to disclose